MAPT and Alzheimer disease: This indicates the causal role of misfolded/aggregated TBI-generated tau in toxicity and supports the nematode and our TBI mouse models for the assessment of the Aβ1-6A2V(D) as a novel therapeutic agent in acquired forms of AD.